Skip to main content
. 2019 Jul 10;11:6379–6396. doi: 10.2147/CMAR.S201610

Table 1.

Correlation between DNMT3a expression and clinicopathological characteristics in 118 cases of PDAC

Characteristics All cases (N=118) DNMT3a expression χ2 value P-value
Low (%) High (%)
Age (years)
 <60 56 33 (28.0) 23(19.5)
 ≥60 62 38 (32.2) 24(20.3) 0.068 0.794
Gender
 Female 52 38 (32.2) 14(11.9)
 Male 66 33 (28.0) 33(28.0) 6.463 0.011
Tumor size(cm)
 <4 51 35(29.7) 16(13.6)
 ≥4 67 36(30.5) 31(26.3) 2.681 0.102
TNM stage
 I 48 35 (29.7) 13(11.0)
 Ⅱ+Ⅲ 70 36 (30.5) 34(28.8) 5.486 0.019
Differentiation
 Moderate-well 100 65(55.1) 35(29.7)
 Poor 18 6(5.1) 12(10.2) 6.383 0.012
Vascular invasion
 No 62 42(35.6) 20(16.9)
 Yes 56 29(24.6) 27(22.9) 3.126 0.077
Perineural invasion
 No 95 56(47.5) 39(33.1)
 Yes 23 15(12.7) 8(6.8) 0.304 0.582
Ki67
 ≤20 86 60 (50.8) 26(22.0)
 >20 32 11(9.3) 21(17.8) 12.19 0.001

Abbreviations: DNMT, DNA methyltransferase; PDAC, pancreatic ductal adenocarcinoma.